Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telemonitored Fast Sequencing for HFrEF (TELE-FASTER)
NCT05637853Phase 4Active, not recruiting
- Sponsor
- University of Gothenburg
- Start
- Oct 2022
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in heart failure with reduced ejection fraction (HFrEF), sponsored by University of Gothenburg. Primary endpoint: Safety and feasibility of fast telemonitored sequencing of heart failure medications at 180 days. Started Oct 2022; status: active, not recruiting.
02
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT05637853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05637853.